Legal & General Group
ABEO icon

Legal & General Group’s Abeona Therapeutics ABEO Stock Holding History

Legal & General Group’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.8K Sell
3,975
-629
-14% -$3.14K ﹤0.01% 3002
2025
Q4 		$24.3K Sell
4,604
-211
-4% -$1.06K ﹤0.01% 2953
2025
Q3 		$25.4K Hold
4,815
– – ﹤0.01% 2948
2025
Q2 		$27.3K Buy
+4,815
New +$27.4K ﹤0.01% 2885
2021
Q2 		– Sell
-239
Closed -$11K – 3475
2021
Q1 		$11K Hold
239
– – ﹤0.01% 3341
2020
Q4 		$9K Hold
239
– – ﹤0.01% 3358
2020
Q3 		$6K Sell
239
-102
-30% -$6.43K ﹤0.01% 3355
2020
Q2 		$25K Buy
341
+77
+29% +$5.32K ﹤0.01% 2962
2020
Q1 		$14K Buy
264
+52
+25% +$3.47K ﹤0.01% 3043
2019
Q4 		$17K Hold
212
– – ﹤0.01% 3217
2019
Q3 		$12K Hold
212
– – ﹤0.01% 3237
2019
Q2 		$25K Hold
212
– – ﹤0.01% 3113
2019
Q1 		$39K Buy
212
+27
+15% +$4.83K ﹤0.01% 2800
2018
Q4 		$33K Hold
185
– – ﹤0.01% 2861
2018
Q3 		$59K Hold
185
– – ﹤0.01% 2691
2018
Q2 		$74K Sell
185
-19
-9% -$8.3K ﹤0.01% 2589
2018
Q1 		$73K Sell
204
-85
-29% -$31.6K ﹤0.01% 2582
2017
Q4 		$115K Buy
289
+22
+8% +$9.1K ﹤0.01% 2514
2017
Q3 		$117K Buy
267
+125
+88% +$33.6K ﹤0.01% 2559
2017
Q2 		$23K Buy
+142
New +$19.4K ﹤0.01% 3126

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Legal & General Group's ABEO Position: Q1 2026 in Review

Legal & General Group reduced its Abeona Therapeutics (ABEO) stake by 14% in Q1 2026, selling an estimated $3.14K and leaving 3,975 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3002.

Legal & General Group first reported a position in ABEO in Q2 2017 and has held it in 20 quarters since. The position peaked at $117K in Q3 2017. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Legal & General Group held 3,975 shares of Abeona Therapeutics worth $17.8K as of Q1 2026.
  • Legal & General Group sold 629 Abeona Therapeutics shares in Q1 2026, an estimated $3.14K.
  • Abeona Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3002 holding.
  • Legal & General Group first reported a position in Abeona Therapeutics in Q2 2017 and has held it in 20 quarters since.
  • Legal & General Group's Abeona Therapeutics position peaked at $117K in Q3 2017.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.